Kessler Foundation researchers report results of a clinical trial showing that a specific type of memory training improves learning in people with MS for at least six months after the training has ended—and benefits other aspects of quality of life as well. These results could help improve insurance coverage of cognitive therapy moving forward. Get the study details
Related: How exercise impacts memory is the focus of one of three new studies looking into lifestyle choices and MS.
The Society invested $48 million this year to drive 380 new and ongoing MS studies, including a clinical trial in ibudilast for progressive MS. Lives moved forward with the FDA approval of a third oral MS therapy, results of studies testing novel cell-based repair strategies, and much more.
This communication is partially sponsored through the generous support of Biogen Idec; Genzyme, a Sanofi company; Novartis Pharmaceuticals Corporation; and Teva Neuroscience, Inc.
MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS. JOIN THE MOVEMENT®
Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please visit our website.
Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.
National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017
This message was sent to . To ensure that you continue to receive our emails, please add us to your address book.